These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 6138259)

  • 1. Cerebrospinal fluid [Met5]enkephalin level in schizophrenics during treatment with naloxone.
    Lo CW; Wen HL; Ho WK
    Eur J Pharmacol; 1983 Aug; 92(1-2):77-81. PubMed ID: 6138259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naloxone and [Met5]enkephalin effects on retention: attenuation by adrenal denervation.
    Zhang SY; McGaugh JL; Juler RG; Introini-Collison IB
    Eur J Pharmacol; 1987 Jun; 138(1):37-44. PubMed ID: 3622607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Met5-enkephalin-Arg6-Gly7-Leu8 immunoreactivity in rat and human cerebrospinal fluid: influence of neuroleptic drugs and electroconvulsive shock.
    Iadarola MJ; Flores CM; Cadet JL; Suddath R; Illowsky B; Berman KF
    Brain Res; 1988 Nov; 474(1):75-85. PubMed ID: 2905617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naloxone-induced reduction of schizophrenic symptoms.
    Jørgensen HA; Cappelen C
    Acta Psychiatr Scand; 1982 May; 65(5):370-4. PubMed ID: 6126068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term naloxone administration in schizophrenic and manic patients. A World Health Organization Collaborative Study.
    Pickar D; Vartanian F; Bunney WE; Maier HP; Gastpar MT; Prakash R; Sethi BB; Lideman R; Belyaev BS; Tsutsulkovskaja MV; Jungkunz G; Nedopil N; Verhoeven W; van Praag H
    Arch Gen Psychiatry; 1982 Mar; 39(3):313-9. PubMed ID: 6121545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Met-enkephalin level in the cerebrospinal fluid of schizophrenic patients.
    Wen HL; Lo CW; Ho WK
    Clin Chim Acta; 1983 Mar; 128(2-3):367-71. PubMed ID: 6851144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of [Met5]enkephalin on regional blood flow and vascular resistance in rabbits.
    Eulie PJ; Rhee HM; Laughlin MH
    Eur J Pharmacol; 1987 May; 137(1):25-31. PubMed ID: 3609133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Met5]enkephalin concentrations in rat pituitary are maintained under opioid inhibition.
    George SR; Kertesz M
    Eur J Pharmacol; 1987 Aug; 140(1):95-8. PubMed ID: 3622625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeated high dosage naloxone treatment without therapeutic efficacy in schizophrenic patients.
    Naber D; Leibl K
    Pharmacopsychiatria; 1983 Mar; 16(2):43-5. PubMed ID: 6346348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Met5]enkephalin acts via delta-opioid receptors to inhibit pelvic nerve-evoked contractions of cat distal colon.
    Kennedy C; Krier J
    Br J Pharmacol; 1987 Oct; 92(2):291-8. PubMed ID: 2823946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonism of the Met5-enkephalin-opioid growth factor receptor-signaling axis promotes MSC to differentiate into osteoblasts.
    Thakur NA; DeBoyace SD; Margulies BS
    J Orthop Res; 2016 Jul; 34(7):1195-205. PubMed ID: 26687326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Normal CSF levels of met-enkephalin-like material in a case of naloxone-reversible congenital insensitivity to pain.
    Cesselin F; Bourgoin S; Hamon M; Artaud F; Testut MF; Rascol A; Montastruc JL
    Neuropeptides; 1984 May; 4(3):217-25. PubMed ID: 6462379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presynaptic opioid delta-receptors in the rabbit mesenteric artery.
    Illes P; Ramme D; Starke K
    J Physiol; 1986 Oct; 379():217-28. PubMed ID: 3031283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of cAMP on cerebrospinal fluid opioid concentration: role in cAMP-induced pial artery dilation.
    Wilderman MJ; Armstead WM
    Eur J Pharmacol; 1996 Aug; 309(3):243-9. PubMed ID: 8874147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Action of enkephalin analogues and morphine on brain acetylcholine release: differential reversal by naloxone and an opiate pentapeptide.
    Jhamandas K; Sutak M
    Br J Pharmacol; 1980; 71(1):201-10. PubMed ID: 7470736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunologic action of [Met5]enkephalin fragments.
    Kowalski J
    Eur J Pharmacol; 1998 Apr; 347(1):95-9. PubMed ID: 9650853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of [D-Ala2,Met5]enkephalinamide and [D-Ala2,D-Leu5]enkephalin on cholinergic and noradrenergic neurotransmission in isolated atria.
    Wong-Dusting HK; Rand MJ
    Eur J Pharmacol; 1985 Apr; 111(1):65-72. PubMed ID: 2990945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of precipitated withdrawal from spinal morphine: changes in [Met5]enkephalin levels.
    Cridland RA; Sutak M; Jhamandas K
    Eur J Pharmacol; 1991 Oct; 203(1):93-103. PubMed ID: 1797559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-endorphin-, leucine enkephalin- and methionine enkephalin-like immunoreactivity in human cerebrospinal fluid. Simultaneous determination and relation to neurological disorders.
    Neuser D; Lesch KP; Stasch JP; Przuntek H
    Eur Neurol; 1984; 23(2):73-81. PubMed ID: 6327313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indication of an antipsychotic action of the opiate antagonist naloxone.
    Emrich HM; Cording C; Pirée S; Kölling A; von Zerssen D; Herz A
    Pharmakopsychiatr Neuropsychopharmakol; 1977 Sep; 10(5):265-70. PubMed ID: 30101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.